These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33470124)

  • 1. Autocrine Signaling in Cardiac Remodeling: A Rich Source of Therapeutic Targets.
    Segers VFM; De Keulenaer GW
    J Am Heart Assoc; 2021 Feb; 10(3):e019169. PubMed ID: 33470124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
    Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.
    Lionetti V; Bianchi G; Recchia FA; Ventura C
    Heart Fail Rev; 2010 Nov; 15(6):531-42. PubMed ID: 20364318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTGF/CCN2 is an autocrine regulator of cardiac fibrosis.
    Dorn LE; Petrosino JM; Wright P; Accornero F
    J Mol Cell Cardiol; 2018 Aug; 121():205-211. PubMed ID: 30040954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling.
    Li J; Salvador AM; Li G; Valkov N; Ziegler O; Yeri A; Yang Xiao C; Meechoovet B; Alsop E; Rodosthenous RS; Kundu P; Huan T; Levy D; Tigges J; Pico AR; Ghiran I; Silverman MG; Meng X; Kitchen R; Xu J; Van Keuren-Jensen K; Shah R; Xiao J; Das S
    Circ Res; 2021 Jan; 128(1):e1-e23. PubMed ID: 33092465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?
    Martin ML; Blaxall BC
    J Cardiovasc Transl Res; 2012 Dec; 5(6):768-82. PubMed ID: 23015462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.
    Zhao X; Balaji P; Pachon R; Beniamen DM; Vatner DE; Graham RM; Vatner SF
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2451-9. PubMed ID: 26338300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear Receptor Nur77 Controls Cardiac Fibrosis through Distinct Actions on Fibroblasts and Cardiomyocytes.
    Medzikovic L; Heese H; van Loenen PB; van Roomen CPAA; Hooijkaas IB; Christoffels VM; Creemers EE; de Vries CJM; de Waard V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
    Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
    Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling.
    Malekar P; Hagenmueller M; Anyanwu A; Buss S; Streit MR; Weiss CS; Wolf D; Riffel J; Bauer A; Katus HA; Hardt SE
    Hypertension; 2010 Apr; 55(4):939-45. PubMed ID: 20177000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G(13)-mediated signaling pathway is required for pressure overload-induced cardiac remodeling and heart failure.
    Takefuji M; Wirth A; Lukasova M; Takefuji S; Boettger T; Braun T; Althoff T; Offermanns S; Wettschureck N
    Circulation; 2012 Oct; 126(16):1972-82. PubMed ID: 22972902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory RNAs and paracrine networks in the heart.
    Viereck J; Bang C; Foinquinos A; Thum T
    Cardiovasc Res; 2014 May; 102(2):290-301. PubMed ID: 24562768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
    Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
    J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease.
    Hall C; Gehmlich K; Denning C; Pavlovic D
    J Am Heart Assoc; 2021 Feb; 10(5):e019338. PubMed ID: 33586463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial Mesenchymal Transition in Hypoxic Microvascular Endothelial Cells and Paracrine Induction of Cardiomyocyte Apoptosis Are Mediated via TGFβ₁/SMAD Signaling.
    Sniegon I; Prieß M; Heger J; Schulz R; Euler G
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.
    Schirone L; Forte M; Palmerio S; Yee D; Nocella C; Angelini F; Pagano F; Schiavon S; Bordin A; Carrizzo A; Vecchione C; Valenti V; Chimenti I; De Falco E; Sciarretta S; Frati G
    Oxid Med Cell Longev; 2017; 2017():3920195. PubMed ID: 28751931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.
    Panse KD; Felkin LE; López-Olañeta MM; Gómez-Salinero J; Villalba M; Muñoz L; Nakamura K; Shimano M; Walsh K; Barton PJ; Rosenthal N; Lara-Pezzi E
    J Cardiovasc Transl Res; 2012 Dec; 5(6):814-26. PubMed ID: 22915069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac nonmyocytes in the hub of cardiac hypertrophy.
    Kamo T; Akazawa H; Komuro I
    Circ Res; 2015 Jun; 117(1):89-98. PubMed ID: 26089366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide induced activin A-follistatin imbalance affects cardiac fibrosis.
    Zhang WQ; Yang CY; Li SM; Liu M; Ding M; Liu GH; Yang P
    Chin Med J (Engl); 2012 Jun; 125(12):2205-12. PubMed ID: 22884154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
    Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
    Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.